Season with garlic salt
T., Souzdalnitski, D., Vrooman, B., & Cheng, J
The regulatory and legal status of BPC-157 is that of an unapproved research compound in the United States and in most global jurisdictions, with no marketing authorization from any major regulatory agency for human therapeutic use
What Research Shows A 20192020 study in Orlando: BPC-157 alone 91.6% reported major knee pain relief BPC-157 + TB-4 75% experienced significant improvement Overall success rate 87.5% reported meaningful pain reduction Animal studies also show BPC-157 preserved cartilage, improved mobility, and prevented joint damage in osteoarthritis models
The SS-31 benefits guide covers the mitochondrial support mechanism in detail, while the broader role of energy-supporting peptides provides additional context
doi: 10.1002/jcp.v234.9 97 FujisakaSAvila-PachecoJSotoMKosticADreyfussJMPanHet al